Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Arimoclomol
.
Show all posts
Showing posts with label
Arimoclomol
.
Show all posts
Friday, August 16, 2024
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
›
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) a rare disease therapeutics company, today announced it resubmitted its New Drug Application (NDA)...
›
Home
View web version
